Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole - Test2 - elhamkhani - TriplyDB

Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

http://www.wikidata.org/entity/Q26782472

about

Antifungal Prophylaxis in Immunocompromised Patients An update on the safety and interactions of antifungal drugs in stem cell transplant recipients.Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients.

P2860

Q28074168-C8F6F46C-E5AD-4A0A-80E0-DDDE92ED7C2D Q39048531-D816E215-722A-4BFD-9628-B3636753708C Q39553916-0D456CFA-ADE4-4A68-A783-3FF6F23E1D7E Q48118247-4B938857-6A25-47EA-9D63-4F5293C28B98

P2860

Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

http://www.wikidata.org/entity/Q26782472

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Prevention of invasive fungal ...... f delayed-release posaconazole

@ast

Prevention of invasive fungal ...... f delayed-release posaconazole

@en

Prevention of invasive fungal ...... f delayed-release posaconazole

@nl

type

label

Prevention of invasive fungal ...... f delayed-release posaconazole

@ast

Prevention of invasive fungal ...... f delayed-release posaconazole

@en

Prevention of invasive fungal ...... f delayed-release posaconazole

@nl

prefLabel

Prevention of invasive fungal ...... f delayed-release posaconazole

@ast

Prevention of invasive fungal ...... f delayed-release posaconazole

@en

Prevention of invasive fungal ...... f delayed-release posaconazole

@nl

P1433

Q26782472-446ABCA3-7A49-40E2-9648-4724BF32A4FF

P1476

Q26782472-D3788561-4FBF-4442-B766-F974581C48A5

P2093

Q26782472-350E7B6C-72F1-4BE8-A8EC-41B8B8C302AF

P2860

Q26782472-0036E1D8-3FE2-4FAC-9636-AF6F0025E790

Q26782472-02BA89A0-749E-4240-B4D7-8ECC96722721

Q26782472-09F11AB2-75F6-4C10-8AF5-FC168A262B40

Q26782472-0F088535-12E9-49CA-845C-56205F2711E0

Q26782472-105E27D7-FC3A-4C42-8174-DDACB93621EC

Q26782472-1B4F82E7-9090-4884-86B5-99DD88CF2802

Q26782472-207483D3-A0E4-4C87-A9E7-C9880BCB792B

Q26782472-2187621C-7082-454D-B554-7225015BBACF

Q26782472-21CD1AE4-BAC6-4B83-8A0A-39C340C63819

Q26782472-28B9A0B7-1AA3-4D7E-93F6-0F727E1C2A9C

P304

Q26782472-741F2866-28B9-4F69-BE23-91C576BE12E4

P31

Q26782472-AAB13585-51FB-4A7E-8DF4-CF3A7B1B9C74

P3181

Q26782472-D696D152-C0C4-459F-838F-21C8835CD221

P356

Q26782472-88656830-E781-4E08-9FEE-DC5B8616AAB0

P407

Q26782472-3248F831-ABE9-4285-BBD2-DE00EED74564

P478

Q26782472-D77C9BA0-BBDC-43AE-B1AB-472C9343A2DA

P577

Q26782472-5B08DEFD-9066-40E7-B7B8-3EEAB60B23A9

P698

Q26782472-7CA2AE53-32D4-4ECB-A407-22F384C5837D

P932

Q26782472-C3C04F9B-C345-4012-99F0-1EA12499AD17

P3181

P356

P1433

Infection and Drug Resistance

P1476

Prevention of invasive fungal ...... f delayed-release posaconazole

@en

P2093

Ahmet Soysal

http://www.w3.org/2001/XMLSchema#string

P2860

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects.

Primary immunodeficiencies underlying fungal infections

Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study.

Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands.

Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.

Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

P304

321-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3741574

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/IDR.S65592

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26392781

http://www.w3.org/2001/XMLSchema#string

P932

4573198

http://www.w3.org/2001/XMLSchema#string